Work

Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial

Year: 2024

Type: preprint

Source: Research Square

DOI: 10.21203/rs.3.rs-3972285/v1

Authors: Ke Zhang, Qifeng Wang, Jianzhong Cao, Chengcheng Fan, Wenbin Shen, Qin Xiao, Xiaolin Ge, Tian Zhang, Xiao Liu, Xi Chen, Jie Dong, Zewei Li, Zhunhao Zheng, Cihui Yan, Ping Wang, Qingsong Pang, Wencheng Zhang

Institutions: Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, University of Electronic Science and Technology of China, Sichuan Cancer Hospital, Shanxi Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Shanxi Provincial Cancer Hospital, Zhengzhou University, Henan Cancer Hospital, Fourth Hospital of Hebei Medical University, Central South University, Hunan Cancer Hospital, Jiangsu Province Hospital, Nanjing Medical University

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: BeiGene

OpenAlex ID: W4392186207

Cites: 19

Cited by:

Related to: 10